Transactions - Laidlaw & Company

admin2023-05-23T18:00:13+00:00

BioSig Technologies

PIPE Transaction

$2,500,000

.

At The Market Offering
May 2023

admin2023-04-24T20:59:32+00:00

Serve Robotics Inc

Secured Convertible Debenture

$3,000,000

.

Introducing Broker
April 2023

admin2023-04-19T13:01:38+00:00

PD Theranostics

Series A Financing

$3,000,000

.

Exclusive Placement Agent
April 2023

admin2023-04-19T13:57:32+00:00

Viking Therapeutics

Follow-On Offering

$287,500,000

.

Co-Manager
March 2023

admin2023-03-02T17:04:43+00:00

Guerilla RF, Inc

PIPE Transaction

$9,200,000

.

Exclusive Placement Agent
February 2023

admin2023-02-27T21:33:44+00:00

The NFT Gaming Company

Initial Public Offering

$7,000,000

.

Lead Book Runner
February 2023

admin2023-03-02T16:35:24+00:00

BioSig Technologies

PIPE Transaction

$7,300,000

.

Introducing Broker
January 2023

admin2023-03-02T16:36:00+00:00

Hoth Therapeutics

PIPE Transaction

$10,000,000

.

Financial Advisor
January 2023

admin2022-12-19T17:18:52+00:00

NLS Pharmaceutics

Private Placement

$10,000,000 of up to $30,000,000

Investor: BVF Partners L.P.

Exclusive Introducing Broker
December 2022

admin2023-01-05T20:28:51+00:00

Perfect Moment

Private Placement

$6,000,000

.

Exclusive Placement Agent
October 2022

admin2023-01-29T00:07:18+00:00

NLS Pharmaceutics

Private Placement

$4,000,000

.

Sole Placement Agent
October 2022

admin2023-03-02T16:42:04+00:00

Silo Pharma

Follow-On Offering

$5,750,000

.

Sole Book runner
September 2022

admin2022-08-31T11:50:35+00:00

Amesite, Inc.

Registered Direct Offering

$2,300,000

Sole Placement Agent
August 2022

admin2022-12-19T17:29:28+00:00

Perfect Moment

Secured Convertible Note

.

$10,000,000

Exclusive Placement Agent
June 2022

admin2022-06-28T13:20:36+00:00

BioSig Technologies

Follow-On
Offering
Common Stock

$3,500,000

Sole Book-Runner
June 2022

admin2022-05-04T15:44:42+00:00

Odyssey Group
International Inc.

PIPE
Common Stock
and Warrants

$1,420,430

Exclusive Placement Agent
May 2022

admin2022-03-31T20:35:18+00:00

Soleno Therapeutics

Follow-On Offering
Common Stock
and Warrants

$15,000,000

Co-Manager
March 2022

admin2022-03-31T20:34:23+00:00

Cohen & Steers

Initial Public Offering
Common Stock

$367,886,900

Initial Public Offering
February 2022

admin2022-03-31T20:33:00+00:00

Amesite, Inc.

Follow-On Offering
Common Stock

$3,000,000

Sole-Book Runner
February 2022

admin2022-12-19T17:30:34+00:00

Pimco Access Income Fund

Initial Public
Offering
Common Stock

$866,000,000

Co-Manager
January 2022

Daniel Malowany2022-02-07T14:53:34+00:00

Cingulate, Inc.

Initial Public Offering
Common Stock
and Warrants

$25,000,000

Co-Lead Bookrunner
December 2021

Daniel Malowany2022-01-17T17:57:40+00:00

MEI
Pharma

PIPE Transaction
Follow-on Offering
Common Stock

$52,325,000

Financial Advisor
December 2021

admin2022-01-18T14:13:31+00:00

Voltron
Therapeutics

Series B
Preferred Offering

$4,000,000

Exclusive Placement Agent
November 2021

Daniel Malowany2022-01-17T18:20:03+00:00

Guggenheim Active Allocation Fund.

Initial Public Offering
Common Stock

$655,000,000

Co-Manager
November 2021

Daniel Malowany2022-12-19T17:28:08+00:00

EyePoint Pharmaceuticals

Follow-On Offering
Common Stock

.$115,000,000

Financial Advisor
November 2021

admin2022-01-17T18:11:46+00:00

aTyr Pharma Inc.

Follow-On Offering
Common Stock

$86,250,000

Lead Manager
September 2021

Daniel Malowany2022-01-17T17:53:39+00:00

Blackrock ESG Capital Allocation Trust

Initial Public Offering
Common Stock

$2,040,000,000

Co-Manager
September 2021

admin2022-01-17T17:55:11+00:00

BioSig Technologies

Follow-On
Offering
Common Stock

$10,000,000

Sole Book-Runner
July 2021

admin2022-01-18T14:13:53+00:00

Perfect Moment

Private
Placement

$6,000,000

Exclusive Placement Agent
May 2021

admin2022-01-15T17:32:42+00:00

Aldeyra Therapeutics

Follow-On Offering
Common Stock
.

$125,000,000

Co-Manager
April 2021

admin2022-02-03T15:48:44+00:00

Algorithm
Sciences

Series B
Offering

$5,000,000

Exclusive Placement Agent
April 2021

admin2022-01-15T17:34:02+00:00

iCAD Inc.

Follow-On Offering
Common Stock
.

$25,000,000

Co-Manager
March 2021

admin2022-01-18T14:14:20+00:00

Aerwave
Medical

Series A
Offering

$4,000,000

Exclusive Placement Agent
February 2021

admin2022-01-15T17:36:29+00:00

EyePoint Pharmaceuticals

Follow-On Offering
Common Stock
.

$115,000,000

Financial Advisor
February 2021

admin2022-01-15T17:24:47+00:00

Evoke Pharma

Follow-On Offering
Common Stock
.

$14,375,000

Sole Book-Runner
January 2021

Daniel Malowany2022-01-15T17:05:00+00:00

Affimed

Follow-On Offering
Common Stock
.

$115,00,000

Co-Manager
January 2021

Daniel Malowany2022-01-15T17:39:59+00:00

Curis Inc.

Follow-On Offering
Common Stock
.

$169,625,000

Lead Manager
December 2020

Daniel Malowany2022-01-15T17:41:24+00:00

Delcath Systems

Follow-On Offering
Common Stock
.

$22,247,000

Financial Advisor
December 2020

Daniel Malowany2022-02-16T13:07:36+00:00

Amesite, Inc

Initial Public Offering
Common Stock
.

$15,00,000

Sole Book Runner
Sept 2020

admin2022-01-18T14:14:47+00:00

PD Theranostics

Series A Offering

$3,000,000

Exclusive Placement Agent
August 2020

Daniel Malowany2022-01-17T17:50:44+00:00

Arcturus Therapeutics

Follow-On Offering
Common Stock
.

$173,000,000

Financial Advisor
July 2020

Daniel Malowany2022-01-15T17:50:11+00:00

Soleno Therapeutics

Follow-On Offering
Common Stock
.

$50,000,000

Co-Manager
June 2020

admin2022-01-18T14:15:14+00:00

Voltron
Therapeutics

Series A
Preferred Offering

$3,500,000

Exclusive Placement Agent
June 2020

Daniel Malowany2022-01-15T17:46:06+00:00

ViralClear Pharmaceuticals

Private Placement
Common Stock
.

$10,800,000

Introducing Broker
May 2020

admin2022-01-18T14:10:11+00:00

Amesite Inc

Exclusive
Placement
Agent

$1,000,000

May 2020

Daniel Malowany2022-01-15T17:46:35+00:00

Delcath Systems

Follow-On Offering
Common Stock
.

$22,000,000

Co-Lead Manager
May 2020

Daniel Malowany2022-01-15T17:46:59+00:00

Arcturus Therapeutics

Follow-On Offering
Common Stock
.

$70,000,000

Financial Advisor
April 2020

Monalisa Moody2022-01-15T17:53:39+00:00

Hoth Therapeutics

Follow-On
Common Stock
.

$5,000,000

Sole-Book Runner
March 2020

Daniel Malowany2022-01-17T18:15:33+00:00

EyePoint Pharmaceuticals

Follow-On Offering
Common Stock
.

$21,800,000

Co-Manager
February 2020

Daniel Malowany2022-01-18T14:17:48+00:00

BioSig Technologies

Follow-On Offering
Common Stock

$10,000,000

Sole Book-Runner
February 2020

admin2022-02-03T15:49:41+00:00

Algorithm
Sciences

Series A
Offering

$3,500,000

Exclusive Placement Agent
February 2020

Daniel Malowany2022-01-15T18:03:05+00:00

Ziopharm Oncology

Follow-On Offering
Common Stock
.

$90,000,000

Co-Manager
February 2020

Daniel Malowany2022-01-15T18:03:52+00:00

Beyond Air

Follow-On Offering
Common Stock
.

$10,500,000

Financial Advisor
December 2019

Daniel Malowany2022-01-15T18:45:29+00:00

Molecular
Templates, Inc.

Follow-On Offering
Common Stock & Convertible Preferred Stock

$50,000,000

Financial Advisor
November 2019

Daniel Malowany2022-01-15T18:04:35+00:00

Affimed

Follow-On Offering
Common Stock
.

$34,500,000

Co-Manager
November 2019

Daniel Malowany2022-01-15T18:46:54+00:00

Soleno Therapeutics

Follow-On Offering
Common Stock
.

$15,400,000

Co-Manager
October 2019

Daniel Malowany2022-01-15T18:05:26+00:00

Hoth Therapeutics

Private Placement
Common Stock
.

$2,037,000

Exclusive Placement Agent
September 2019

Daniel Malowany2022-01-15T18:16:17+00:00

Noxopharm, Ltd

Funding Facility

$26,000,000

Sole Financial Advisor
July 2019

Daniel Malowany2022-01-15T18:11:00+00:00

Icad, Inc

Follow-On Offering
Common Stock
.

$9,000,000

Financial Advisor
June 2019

Daniel Malowany2022-01-15T18:49:45+00:00

Athenex, Inc

Block Trade

$20,000,000

Sole Broker
April 2019

Daniel Malowany2022-01-15T18:55:34+00:00

EyePoint Pharmaceuticals

Follow-On Offering
Common Stock
.

$20,000,000

Co-Manager
March 2019

Daniel Malowany2022-01-15T18:56:16+00:00

Hoth Therapeutics

Initial Public Offering
Common Stock
.

$7,000,000

Sole Book Runner
February 2019

Daniel Malowany2022-01-15T18:56:31+00:00

Taiwan
Liposome Company

Initial Public Offering
Common Stock
.

$21,750,000

Co-Manager
November 2018

Daniel Malowany2022-01-15T18:57:38+00:00

Tiziana
Life Sciences

Initial Public Offering
Common Stock
.

$7,000,000

Sole Book Runner
November 2018

Daniel Malowany2022-01-15T19:01:12+00:00

Molecular
Templates, Inc.

Follow-On Offering
Common Stock
.

$45,100,000

Lead Manager
September 2018

Daniel Malowany2022-01-15T19:02:00+00:00

Viking
Therapeutics

Follow-On Offering
Common Stock
.

$175,800,000

Financial Advisor
September 2018

Daniel Malowany2022-01-17T17:48:49+00:00

Aldeyra Therapeutics

Follow-On Offering
Common Stock
.

$72,187,500

Co-Manager
September 2018

Daniel Malowany2022-01-15T19:02:24+00:00

BioSig Technologies

PIPE Transaction
Common Stock
& Warrants

$6,000,000

Introducing Broker
August 2018

Daniel Malowany2022-01-15T19:11:24+00:00

Aridis Pharmaceuticals

Initial Public
Offering
Common Stock

$26,000,000

Co-Manager
August 2018

admin2022-01-17T17:49:11+00:00

WatchTower
Investments, LLC

Member Interests

$16,348,970

August 2018

Daniel Malowany2022-01-15T19:11:54+00:00

Athenex, Inc

PIPE Transaction
Common Stock, Warrants & Senior Debt

$100,000,000

Exclusive Placement Agent
July 2018

Daniel Malowany2022-01-15T19:22:01+00:00

Viking
Therapeutics

Follow-On Offering
Common Stock

$78,000,000

Financial Advisor
June 2018

Daniel Malowany2022-01-15T19:23:03+00:00

MEI
Pharma

PIPE Transaction
Common Stock and
Warrants

$75,000,000

Co-Placement Agent
May 2018

Daniel Malowany2022-01-17T17:47:54+00:00

Sesen
Bio

Follow-On Offering
Common Stock
.

$48,000,000

Financial Advisor
May 2018

admin2022-01-15T19:22:31+00:00

Sesen
Bio

Registered Direct
Common Stock and
Warrants

$10,000,000

Exclusive Placement Agent
March 2018

admin2022-01-15T19:18:09+00:00

AIT Therapeutics

PIPE Transaction
Warrants
.

$9,820,154.54

Exclusive Placement Agent
February 2018

Daniel Malowany2022-01-15T19:18:29+00:00

Hoth Therapeutics

Private Placement
Series A
Preferred Warrants

$3,102,480

Exclusive Placement Agent
February 2018

Daniel Malowany2022-01-15T19:23:26+00:00

Affimed

Follow-On Offering
Common Stock

$23,000,000

Financial Advisor
February 2018

Daniel Malowany2022-01-15T19:23:37+00:00

Gemphire

Follow-On
Offering
Common Stock

$22,000,000

Co-Manager
February 2018

admin2022-01-17T17:47:15+00:00

Athenex, Inc

Follow-On
Offering
Common Stock

$65,575,000

Co-Manager
January 2018

admin2022-01-15T19:27:36+00:00

Fennec
Pharmaceuticals

Follow-On Offering
Common Stock

$20,000,000

Financial Advisor
December 2017

admin2022-01-15T19:28:02+00:00

Cytori
Therapeutics

Rights Offering
Convertible Preferred
Stock and Warrants

$10,000,000

Financial Advisor
November 2017

admin2022-01-15T19:28:54+00:00

Onconova
Therapeutics

Registered Direct
Common Stock

$1,380,000

Sole Placement Agent
November 2017

admin2022-01-15T19:29:16+00:00

ADMA Biologics

Follow-On Offering
Common Stock

$36,500,000

Financial Advisor
November 2017

admin2022-01-16T20:40:18+00:00

US Gold Corporation

Confidentially Marketed Public Offering
Common Stock

$2,500,000

Sole Book Runner
October 2017

admin2022-01-16T21:02:40+00:00

Asterias
Biotherapeutics

Registered Direct
Common Stock

$10,400,000

Financial Advisor
October 2017

admin2022-01-16T20:51:59+00:00

Flexion Therapeutics

Follow-On Offering
Common Stock

$122,400,000

Financial Advisor
October 2017

admin2022-01-16T20:53:01+00:00

Aldeyra Therapeutics

Follow-On Offering
Common Stock

$28,800,000

Lead Manager
September 2017

admin2022-01-16T20:53:43+00:00

MabVax
Therapeutics, Inc

Registered Direct
Common Stock

$2,000,000

Sole Placement Agent
September 2017

admin2022-01-16T21:13:02+00:00

SearchLight
Investments, LLC

Member
Interests

$17,382,225

September 2017

admin2022-01-16T21:07:38+00:00

Spherix, Inc.

Follow-On Offering

$2,500,000

Sole Book Runner
July 2017

admin2022-01-17T17:42:41+00:00

Cooltech
Holding Corp.

Private Placement
Common Stock

$5,688,055

Exclusive Placement Agent
June 2017

admin2022-01-16T21:09:46+00:00

Repros
Therapeutics

Confidentially Marketed
Public Offering
Common Stock and Warrants

$3,000,000

Sole Book-Runner
May 2017

admin2022-01-16T21:10:05+00:00

MabVax
Therapeutics, Inc

Follow-On Offering
Common and
Preferred Stock

$4,100,000

Sole Book-Runner
May 2017

admin2022-01-16T21:10:24+00:00

Flexion
Therapeutics

Convertible Note

$175,000,000

Financial Advisor
May 2017

admin2022-01-16T21:10:41+00:00

Onconova
Therapeutics

Confidentially Marketed
Public Offering
Common Stock

$5,963,517

Sole Book Runner
April 2017

admin2022-01-16T21:11:01+00:00

BioSig Technologies

PIPE Transaction
Common Stocks
& Warrants

$4,349,954

Exclusive Placement Agent
March 2017

admin2022-01-17T17:41:37+00:00

AIT Therapeutics

PIPE Transaction,
Common Stock
and Warrants

$10,200,000

Placement Agent
March 2017

admin2022-01-16T21:12:29+00:00

Therapix
Biosciences

Initial Public Offering
Common Stock

$13,800,000

Sole Book Runner
March 2017

admin2022-01-16T21:12:46+00:00

Gemphire

PIPE Transaction
Common Stock & Warrants

$12,500,000

Co-Manager
March 2017

You are now leaving Laidlaw & Company